Azzad Asset Management Inc /Adv Glaukos Corp Transaction History

Azzad Asset Management Inc /Adv

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Apr 01, 2024	SELL	$47.43 - $84.23 $824,048 - $1.46 Million	-17,374 Closed	0 $0
Q2 2021 Apr 01, 2024	SELL	$73.06 - $97.7 $146 - $195	-2 Reduced 0.01%	17,374 $1.47 Billion
Q1 2021 Apr 01, 2024	BUY	$70.43 - $97.42 $140 - $194	2 Added 0.01%	17,376 $1.46 Billion
Q4 2020 Apr 01, 2024	BUY	$48.9 - $75.26 $849,588 - $1.31 Million	17,374 New	17,374 $1.31 Billion

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.